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Introduction: Depletion of Kupffer cells by gadolinium chloride (GdCl3) reduces the systemic response
during sepsis. The study aim was to investigate the effect of this depletion on hepatic proinﬂammatory
cytokine response to portal endotoxaemia.
Methods: Sixteen Wistar rats were randomised to receive either saline IV (n ¼ 8) or GdCl3 (10 mg/kg IV,
n ¼ 8) six days after bile duct ligation (BDL). 24 h later the animals were perfused for 2 h, using isolated
hepatic perfusion. Aliquots of efﬂuent perfusate were collected at 20-min intervals for cytokine analysis.
Sections of liver were sampled and the hepatic Kupffer cell number of each group was measured using
ED1 immunohistochemistry.
Results: Pre-treatment with GdCl3 resulted in signiﬁcantly reduced serum bilirubin concentrations but
signiﬁcantly elevated serum ALP and AST levels compared to the control group. It was also associated
with a signiﬁcant reduction in Kupffer cell numbers and a corresponding signiﬁcant reduction in hepatic
TNFa and IL-6 production in response to portal endotoxaemia.
Conclusions: Pre-treatment with GdCl3 in jaundiced animals reduced Kupffer cell numbers, attenuated
liver enzyme abnormalities and reduced TNFa and IL-6 in response to portal endotoxaemia. Hepatic
Kupffer cells, therefore, play a signiﬁcant role in the development of an exaggerated inﬂammatory
response in obstructive jaundice.
 2012 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Kupffer cells constitute 80e90% of the ﬁxed tissue macrophages
of the mononuclear phagocytic system and their activation has
great effects on the systemic response during sepsis. A major source
of pro- and anti-inﬂammatory cytokines is the Kupffer cell
population and their inhibition reduces this exaggerated inﬂam-
matory response. In states of experimental and clinical obstructive
jaundice, there is a proinﬂammatory response to endotoxin
stimulus.1,2
Gadolinium chloride (GdCl3) depresses Kupffer cell number and
phagocytic activity.3e5 The selective elimination of Kupffer cells
using GdCl3 is a useful tool in vivo for investigation of obstructive
jaundice where the mononuclear phagocytic system has a critical
role.6e11 This earth metal is soluble at pH5 or less but forms
insoluble colloid complexes in the neutral pH of blood and is
phagocytosed by Kupffer cells.12 Once inside the acid environment
of the endosomalelysosomal compartment of the Kupffer cellfax: þ44 (0) 28 90802242.
(M.A. Taylor).
ciates Ltd. Published by Elsevier Ltgadolinium ions are released resulting in inhibition of phagocytosis
and cellular disintegration.13 Therefore, it also reduces the number
of Kupffer cells and provides an effective strategy for modulation of
the hepatic inﬂammatory response in experimental obstructive
jaundice.
Kennedy et al. demonstrated an improved survival following
endotoxin administration in animals pre-treated with GdCl3 that
underwent bile duct ligation (BDL). This group of animals had
decreased median plasma levels of TNFa compared to BDL animals
not given GdCl3.11 The aim of this study was to investigate the effect
of Kupffer cell depletion on the hepatic proinﬂammatory cytokine
response to portal endotoxaemia in experimental biliary
obstruction.2. Methods
The study was carried out under the instructions and regulations of the United
Kingdom Animals (Scientiﬁc Procedures) Act, 1986 (PPL 2474). 16 Male Wistar rats,
aged 8e10 weeks old, underwent bile duct ligation (BDL). Prior to surgery all
animals were housed in specially designed rooms which were kept at a constant
temperature and humidity with 12 h dark/light cycles. The rats had free access to
standard animal chow and water. Cages were emptied, washed, autoclaved and new
bedding was added twice per week. All surgery was carried out in a separate welld. All rights reserved.
C. Jones et al. / International Journal of Surgery 11 (2013) 46e51 47
ORIGINAL RESEARCHventilated operating theatre. A 2 cm midline abdominal incision was made starting
at the xiphisternum. The peritoneum was opened between clips and a small self-
retaining retractor inserted. The liver was retracted towards the costal margin and
the duodenum lifted up using a small round nosed mosquito clip. The bile duct was
identiﬁed and mobilised using blunt dissection. Two 4/0 silk ligatures were placed
around the bile duct with the proximal one positioned just below the conﬂuence of
the lobar ducts. The duct was then divided ensuring that the portal vein was not in
danger of being injured. The duodenum was returned to the abdomen and a ﬁnal
check was made for haemorrhage. Fiveml of normal saline at body temperaturewas
instilled into the peritoneal cavity before closure. The abdomen was closed in two
layers using 4/0 Vicryl continuous mass closure and a 5/0 undyed Vicryl subcuticular
skin closure.
The rat liver consists of four lobes each with its own extrahepatic biliary tree.
These combine to form the common bile duct, which is contained in the hep-
atoduodenal ligament, before entering the duodenum. The duct is doubly ligated
and divided between the ligatures to reduce the possibility of spontaneous recan-
alisation. It is important to carefully identify the correct level on the CBD at which
the ligation is performed. Low ligation of the duct just at the entrance of the
pancreatic ducts results in a small rise in bilirubin, minimal histological changes,
slight dilation of the larger ducts in the liver and inﬁltration of the portal triads by
histiocytes and lymphocytes. However, ligation near the hilum of the liver results in
moremarked changes with a greater bilirubin rise, proliferation of the bile ducts and
marked inﬁltration of the periportal regions with inﬂammatory cells. To standardise
the procedure the ligation should be performed in the same part of the duct in each
animal. Generally, the ligature is placed just below the entrance of the last lobar
duct.
Six days post BDL they were randomised to receive either saline intravenous
(n ¼ 8) or GdCl3 (10 mg/kg IV, n ¼ 8). The dose and timing were based on the
ﬁndings of previous work.11,14 The intravenous (IV) injection via the tail vein was
performed on the animals after administrations of inhalational anaesthesia (iso-
ﬂurane). Twenty-four hours later the livers of the rats were perfused for 2 h. This
was performed using the isolated hepatic perfusion system, as illustrated in Fig. 1.
In order to assess the effect of endotoxin on the perfused liver two sets of apparatus
arranged in parallel were used. The ﬁrst was completely endotoxin free while in the
second the endotoxin was delivered to the liver. Following equilibration with
endotoxin-free perfusate for 10 min (T ¼ 0e10) perfusion was switched to buffer
containing Escherichia coli serotype 0111:B4 (1.6 mg/ml) (T ¼ 10e20) for 10 min and
subsequently endotoxin-free perfusate for a further 100 min (T ¼ 20e120). The
death of the animals at the end of the experiment was as a consequence of the
venous cannulation and IVC ligation, rather than requiring active termination of
life.
Each set consisted of a reservoir of perfusate, a glass lung and a peristaltic
pump for circulating perfusate from the reservoir, through the glass lung to the
rat liver. A circulating waterbath directed heated water around the outer jackets
on the lungs to ensure that the perfusate in the inside wall of the glass lungs was
at 37.5 C. Perfusate temperature was measured both in the reservoirs and the
inside of the glass lungs using handheld thermometers. PH monitoring of the
perfusate was important, as there is a potential for the perfusate to become acidic
due to the effects of 5% CO2 bubbling through it. The pH was maintained between
7.2 and 7.4 by adding molar NaOH as required. To maintain portal pressure within
constant limits, a pressure transducer was connected to a digital readout box.
Normal values ranged from 7 to 12 kPa throughout the perfusion.
All equipment was sterilised and a full aseptic technique was adhered to
throughout the experiments. Prior to perfusion, the two glass lungs and reservoirsFig. 1. Hepatic perfwere soaked overnight in Decon 70/90. The following day they were placed in
a pipette washer and thoroughly ﬂushed with water for 2 h. They were then dried
and wrapped in autoclave paper and autoclaved for 1 h. Sterile prepacked silastic
catheter tubing was used each time to connect each part of the apparatus. The
KrebseHenseleit perfusate was prepared in a sterile environment and produced
each day. Krebs powder (9.5 g/l, Sigma) wasmixed into 1 L bottles of sterilewater for
irrigation along with 2.1 g of sodium bicarbonate and 0.373 g of calcium chloride
dihydrate. A small sample of perfusate was collected in a nunc tube and stored
at 70 C prior to checking for endotoxin using a quantitative Limulus Amoebocyte
lysate (LAL) chromogenic assay (Quadratech, Epsom, UK). Endotoxin (E. coli serotype
0111:B4, Sigma) was added to the perfusate in the reservoir of Set B. The ﬁnal
concentration of endotoxin used was 1.6 mg/ml.
Aliquots of efﬂuent perfusate were collected at 20-min intervals for subsequent
cytokine analysis, by standard bioassay analysis. Sections of liver from the right lobe
were sampled and the Kupffer cell number in the livers of each of the two groups
was obtained using ED1 immunohistochemistry.
Themonoclonal antibody mouse anti-rat ED1 (Serotec) recognises a single chain
glycoprotein that is expressed by resident and recruited rat hepatic macrophages.14
The antigen in rats which it recognises has many characteristics in common with
CD68 in humans. Several studies have used ED1 as a marker of Kupffer cells in
immunostaining of parafﬁn embedded tissue sections.11,15
Parafﬁn sections (5 mm) were dewaxed in xylene and rehydrated through
a series of graded alcohols. Endogenous peroxidase was blocked by incubation in 3%
hydrogen peroxide in methanol. Sections were then incubated with 4% normal goat
serum in PBS for 30 min prior to incubation with a 1:200 dilution of mouse anti-rat
ED1 in PBS for 1 h at room temperature. After washing three times, the sectionswere
incubated with biotinylated goat anti-mouse/rabbit antibody (1:200) for 30 min at
37 C. The sections were again washed three times and incubated with Streptavidin
AB Complex-HRP for 30 min (Dako A/S, Denmark). A ﬁnal PBS wash was followed by
the application of 3,30-diaminobenzidine tetrahydrochloride (Sigma) activated with
50 ml of 3% H2O2. Finally, the sections were counterstained with Harris’ haema-
toxylin (BDH) and mounted. Positive staining Kupffer cells were counted by Kontron
quantitative microscopy. Eight high power ﬁelds were counted and the number of
cells averaged.
2.1. TNFa
Bioactive TNFa in plasma and perfusatewasmeasured using anMTT tetrazolium
cytotoxicity assay. TNFa-sensitive WEHI-164 clone 13 cells which are murine Balb/c
ﬁbrosarcoma cells were used in this assay (European Collection of Animal Cell
Cultures, Salisbury, Wiltshire, UK). RPMI-1640 was used as the tissue culture
medium, supplemented with 1 mM sodium pyruvate, 2 Mm L-glutamine (L-glu),
100 IU/ml penicillin/100 mg/ml streptomycin (P/S) and 10% heat-inactivated foetal
bovine serum (FBS) (Invitrogen, Paisley, UK). Trypsinization was used to detach the
cells from the ﬂask, which was conﬁrmed by light microscopy. The TNFa-sensitive
WEHI 164 cells were counted and the cell concentration adjusted to 2  105 cells/ml
in WEHI culture medium.
Ten ml of cells and medium was taken from a T75 ﬂask and mixed with 90 ml
trypan blue dye (Sigma). This dye was used for cell counting as it determines the
percentage of viable cells. The mix of cells and trypan was placed on a Mod-Fuchs
haemocytometer (Merck Biochemicals, Dorset, England), which consisted of a grid
divided into 16 small squares. The cell concentration per ml was then calculated.
One hundred ml of cells were seeded and allowed to adhere overnight in
the CO2 incubator. Perfusate and serum samples were diluted in Actinomycinusion system.
Table 1
Serum biochemistry in the two groups (median, minimum andmaximum), NoGdCl3
vs GdCl3, p < 0.05 Mann Whitney test.
No GdCl3 GdCl3 p Value
Med Min Max Med Min Max
Bilirubin 124 111 145 96 82 115 0.003
ALP 252 188 375 322 222 378 0.08
AST 407 356 523 544 416 696 0.005
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(Genzyme Diagnostics, Cambridge, MA, USA) or recombinant human (rHu) (NIBSC,
Potters Bar, UK) TNFa standard was serially diluted in the range 0e2000 pg/ml in
Actinomycin D-supplemented WEHI medium and again 50 ml of each concentration
were added to wells in duplicate.
The following day, 20 ml MTT (Sigma) was added to each well. Following incu-
bation for 5 h, cell viability was determined by adding 50 ml 20% SDS in 10mMHCL to
each well. The next day the absorbance of each well was read on a Thermo-max
microplate reader (Molecular Devices, CA, USA), at a wavelength of 570 nm.
2.2. IL-6
The IL-6 bioassay used murine B9 B-cell hybridoma cells, which are highly
dependent on IL-6 for growth. The growth medium used for B9 cells was RPMI-1640
(Invitrogen) supplemented with 1 mM sodium pyruvate, 2 mM L-glu, P/S, 10% heat-
inactivated FBS, 5 mM 2-mercapto ethanol (ME) and 5% Briclone (hybridoma cloning
medium, IL-6 source, Archport Ltd., Dublin).
On the day of assay the B9 cells in tissue culture mediumwere placed in a 15 ml
falcon tube and centrifuged at 900 rpm for 8 min at room temperature. Superna-
tant was discarded and the resultant cell pellet was resuspended in fresh RPMI-
medium (without briclone) and the centrifugation step repeated. This procedure
was repeated 3 times to ensure complete removal of IL-6. The cell pellet was
resuspended in IL-6 free culture media and cells were counted as for the TNFa
assay. The cell concentration was adjusted to a ﬁnal concentration of
2.5  104 cells/ml.
One hundred ml of cells were seeded into each well of a 96-well microtitre plate.
Serum and perfusate samples were diluted as appropriate using IL-6 e free diluent
(RPMI and supplements minus Briclone) and 100 ml added to the wells in duplicate.
The standard usedwas recombinantmurine IL-6 standardwhichwas serially diluted
in the range 0e1000 pg/ml in IL-6-free culture medium with 100 ml of each
concentration added to the wells in duplicate.
After 4 days incubation at 37 C, 20 ml MTT and, 5 h later, 50 ml 20% SDS (in HCl),
were added to each well. The plate was then incubated for a further 48 h at 37 C.
Following this, the absorbance of each well was read at a wavelength of 570 nm.
2.3. Statistical analysis
The data were recorded on SPSS (version 10.0, SPSS Inc., Chicago, USA) and then
analysed. Non-parametric tests were used due to the small numbers. Related
samples were analysed by Wilcoxon Signed-rank test, while Mann Whitney U test
was used for unrelated samples. A p value of 0.05 was considered statistically
signiﬁcant.3. Results
3.1. Mortality
One animal in the Gadolinium treated group died following
anaesthesia on the day of perfusion. The abdomen was quickly
opened and the portal vein cannulated with some back ﬂow
suggesting that there was still a degree of cardiac output. Perfusion
was commenced within 2 min and the liver appeared to blanch
satisfactorily. There were no other mortalities.3.2. Body weight
Each rat was weighed on the day of BDL (day 1) and on the day
of perfusion (day 8). There was no signiﬁcant difference in weights
between the two groups at day 1 and 8 (p ¼ 0.49 and 0.2 respec-
tively). However, there was a signiﬁcant weight reduction within
each group between day 1 and day 8 (No GdCl3: p¼ 0.01 and GdCl3:
p ¼ 0.01).Fig. 2. Efﬂuent perfusate AST in the two groups, median (IQR), GdCl3 vs no GdCl3,
p ¼ 0.031, Mann Whitney U test.3.3. Serum liver biochemistry
There was a signiﬁcant difference in the serum bilirubin, ALP
and AST between the two groups. In the group treated with GdCl3
there was a signiﬁcantly lower serum bilirubin concentration but
higher ALP and AST concentrations (p ¼ 0.002, 0.08 and 0.005
respectively; Table 1).3.4. Perfusate liver biochemistry
There was a signiﬁcant difference in the efﬂuent AST and LDH
between the GdCl3 and the control group at 80 min (p ¼ 0.031 and
0.004 respectively; Figs. 2 and 3). There was also a signiﬁcant
difference in LDH at 40 min (p ¼ 0.038; Fig. 3).3.5. Kupffer cell number
Pre-treatment with GdCl3 resulted in a signiﬁcant reduction in
the number of ED1 stained cells (No GdCl3: 39 (26e44), GdCl3: 13
(10e15), p ¼ 0.014; Figs. 4 and 5A and B).3.6. Efﬂuent perfusate TNFa
Repeated measures analysis over time, revealed a signiﬁcant
difference in the TNFa levels between the two groups with signif-
icantly less TNFa produced in the GdCl3 group (p ¼ 0.049; Fig. 6).3.7. Efﬂuent perfusate IL-6
Repeated measures analysis over time, revealed a signiﬁcant
difference in efﬂuent perfusate IL-6 levels between the two groups
with signiﬁcantly less IL-6 produced in the GdCl3 group (p ¼ 0.045;
Fig. 7).4. Discussion
Hepatic Kupffer cells play a signiﬁcant role in the systemic
immune response during sepsis and its sequelae.8,11,17 The under-
standing of the contribution of Kupffer cells to the inﬂammatory
response would help in developing immunological and pharma-
cological strategies aimed at attenuating the excessive cytokine
secretion seen in obstructive jaundice and other forms of sepsis and
shock.
Fig. 5. Histological sections demonstrating reduced Kupffer cell population in GdCl3
(B) compared to control group (A).
Fig. 3. Efﬂuent perfusate LDH in the two groups, median (IQR), GdCl3 vs no GdCl3,
p ¼ 0.004, Mann Whitney U test.
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GdCl3 selectively reduced the Kupffer cell number and function
in this experiment, by an unclear mechanism. Initially studies
suggested that GdCl3 only inhibited Kupffer cell phagocytosis.
Husztik and colleagues, through administration of GdCl3 to rats
inhibited the hepatic uptake of both 51Cr-labelled human erythro-
cytes and colloidal carbon. They concluded that GdCl3 interfered
with the process of surface attachment and engulfment.18 However,
more recent studies using immunohistochemical analysis with the
macrophage markers ED1 and ED2 demonstrated elimination of
Kupffer cells after parenteral administration of GdCl3.18 ED1 is
a monoclonal mouse antibody which recognises a single chain
glycoprotein expressed by resident and recruited hepatic macro-
phages and has been used in many studies as a marker for Kupffer
cells.11,16,19
In this study, the administration of GdCl3 24 h prior to isolated
perfusion, reduced the Kupffer cell number by 65%, similar to other
reports.11,16 However, Koo et al., using GdCl3 gained only a 54%
reduction in Kupffer cells 48 h after injection.19 However, this group
did not use a Kupffer cell marker or Kontron quantitative micros-
copy but relied on identiﬁcation using light microscopy counts.
Secondly, the counted Kupffer cells, although present, may not have
been metabolically functioning. The signiﬁcant reduction of 65%
achieved in this study ensures with conﬁdence, that the in vivo
properties of Kupffer cells and their function in the development of
an exaggerated inﬂammatory response to portal endotoxaemia can
be determined.Fig. 4. Kupffer cell number in GdCl3 and no GdCl3 groups, median (IQR), GdCl3 vs no
GdCl3, p ¼ 0.014, Mann Whitney U test.4.2. The effect of GdCl3 on liver physiology
Serum liver biochemistry measured on the day of perfusionwas
signiﬁcantly different between the two groups. Serum bilirubin
concentration was reduced in the GdCl3 group with a paradoxical
increase in ALP and AST, suggesting altered hepatocellular integ-
rity.20,21 In Ruttinger’s study, following 10 ml/kg GdCl3 induced
Kupffer cell blockade, serum AST and ALT were elevated without
histological evidence of liver injury.21 Suzuki and co-workers, using
7 mg/kg, found no such liver enzyme rise.6 Importantly, these
ﬁndings do not suggest structural damage as a result of using
10 mg/kg GdCl3. In this present study the liver architecture
appeared normal on the sections used for ED1
immunohistochemistry.Fig. 6. Efﬂuent perfusate TNFa concentrations in each group, mean  SEM, p ¼ 0.049,
repeated measures analysis.
Fig. 7. Efﬂuent perfusate IL-6 in each group, mean  SEM, p ¼ 0.045, repeated
measures analysis.
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demonstrated less AST and LDH in the GdCl3 treated compared to
the control group, with signiﬁcance being achieved at time 80 min.
Although the levels in both groups were not sufﬁciently high to
suggest hepatic injury from perfusion, less signs of injury were in
the GdCl3 group. Thus the GdCl3 pre-treatment may protect the
liver from the effects of endotoxin exposure possibly as a result of
an attenuated cytokine response.4.3. The effect of GdCl3 on the hepatic proinﬂammatory cytokine
response
There was a signiﬁcant reduction in the proinﬂammatory cyto-
kine response to portal endotoxaemia in the BDL group treated
with GdCl3 24 h prior to perfusion. In combination with immuno-
histochemical conﬁrmation of a signiﬁcant reduction in Kupffer cell
number, this would implicate Kupffer cells as the major source of
proinﬂammatory mediators in this model. The signiﬁcance of this
ﬁnding strengthens the results of an experiment by Kennedy et al.
in which the jaundiced animals, that received GdCl3 had an
increased survival rate and a decreased serum TNFa concentration
following endotoxin challenge.11 By using GdCl3, hepatic Kupffer
cells have been shown to be the major source of TNFa and IL-6 in
sepsis, trauma and pancreatitis.3,8,17,22
In this study, there was a signiﬁcant reduction in TNFa and IL-6
production in response to endotoxaemia in the GdCl3 group. Since
the cytokines continue to be produced, GdCl3 did not eliminate the
entire Kupffer cell population and the remaining cells responded to
the endotoxin challenge by secreting cytokines, or else other cells
within the liver also produce inﬂammatory mediators.23 Iwai et al.
highlighted this by demonstrating that efﬂuent perfusate TNFa and
IL-6 was produced in response to portal endotoxaemia in rats,
which had undergone partial hepatectomy.22 This multi-modal
regulation of the inﬂammatory response is supported by its
attenuation following use of lactulose and conjugated bile salts.24,25
In a similar study, Abraham et al. reported increased TNFa and
IL-6 concentrations following BDL and endotoxaemia, with
decreased survival. However, the blockade of Kupffer cells, using
GdCl3, alleviated this inﬂammatory response and improved
survival.26,27 Therefore, the double hit of BDL and endotoxaemia is
promoted by Kupffer cells and their blockade may prove to be
potentially therapeutic.26,27
In conclusion, hepatic Kupffer cells play a signiﬁcant role in the
development of an exaggerated inﬂammatory response in
obstructive jaundice. Modulation of the Kupffer cell-dependent
inﬂammatory response to endotoxaemia may prove a therapeutic
approach in patients with obstructive jaundice. However, two
factors curb the development of such a treatment. Firstly, it would
need to be safe and not associated with hepatic injury, as GdCl3
alters cytochrome P450 activity, the coagulation cascade andhepatic microvascular perfusion.13,28,29 Secondly, Kupffer cells form
a major part of the body’s immune system.While blockade of these
cells may attenuate the inﬂammatory cytokine response it may
have deleterious effects on other Kupffer cell functions including
phagocytosis, toxin clearance and processing of enterically derived
antigens.
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